Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 8;3(4):100149.
doi: 10.1016/j.imj.2024.100149. eCollection 2024 Dec.

Vagal nerve stimulation for the management of long COVID symptoms

Malik W Z Khan  1 , Muhammad Ahmad  2 , Salma Qudrat  2 , Fatma Afridi  2 , Najia Ali Khan  2 , Zain Afridi  2 , Fahad  2 , Touba Azeem  2 , Jibran Ikram  3
Affiliations
Review

Vagal nerve stimulation for the management of long COVID symptoms

Malik W Z Khan et al. Infect Med (Beijing). .

Abstract

This review investigates the therapeutic potential of vagal nerve stimulation (VNS) in managing long COVID, a condition marked by persistent symptoms following acute SARS-CoV-2 infection. Long COVID manifests as ongoing fatigue, cognitive impairment, and autonomic dysfunction, hypothesized to arise from sustained inflammatory and neurological dysregulation. The vagus nerve, central to modulating systemic inflammation and autonomic homeostasis, represents a promising therapeutic target for symptom alleviation through VNS. A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science to identify studies evaluating VNS in the context of long COVID. Preliminary evidence from small-scale pilot studies suggests VNS may attenuate systemic inflammation through activation of the cholinergic anti-inflammatory pathway (CAP), thus restoring autonomic balance and ameliorating symptoms such as fatigue, cognitive dysfunction, and anxiety. In targeting the inflammatory cascade that underlies both acute COVID-19 pathophysiology and its prolonged sequelae, VNS holds potential as an innovative intervention for persistent post-viral symptoms. While these initial findings indicate promise, current data remain limited in scope and robustness, underscoring the need for larger, controlled trials to validate the efficacy and mechanisms of VNS in long COVID management. Establishing a clearer understanding of VNS's impact on inflammation and autonomic regulation in this context is crucial to inform clinical guidelines and therapeutic strategies for long COVID, potentially offering a targeted approach for mitigating this disabling condition.

Keywords: COVID-19; Invasive vagal nerve stimulation; Long COVID; Non-invasive vagal nerve stimulation; Transcutaneous vagal nerve stimulation.

PubMed Disclaimer

Figures

Image, graphical abstract
Graphical abstract
Fig 1
Fig. 1
A concise summary illustrating the pathophysiology of COVID-19 and its impacts.
See this image and copyright information in PMC

References

    1. Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26(7):1017–1032. doi: 10.1038/s41591-020-0968-3. - DOI - PMC - PubMed
    1. National Institute for Health and Care Excellence . National Institute for Health and Care Excellence.; 2020. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.https://www.nice.org.uk/guidance/ng188 Accessed April 30, 2022. - PubMed
    1. Huerne K., Filion K.B., Grad R., et al. Epidemiological and clinical perspectives of long COVID syndrome. Am. J. Med. Open. 2023;9 doi: 10.1016/j.ajmo.2023.100033. - DOI - PMC - PubMed
    1. Carfì A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603. doi: 10.1001/jama.2020.12603. - DOI - PMC - PubMed
    1. McElvaney O.J., McEvoy N.L., McElvaney O.F., et al. Characterization of the inflammatory response to severe COVID-19 illness. Am. J. Respir. Crit. Care Med. 2020;202(6):812–821. doi: 10.1164/rccm.202005-1583OC. - DOI - PMC - PubMed

LinkOut - more resources